AbbVie Inc. (NYSE:ABBV) Receives $210.95 Consensus Target Price from Analysts
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty-eight research firms that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation, seventeen have issued a buy recommendation and three have issued a strong buy recommendation […]
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty-eight research firms that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation, seventeen have issued a buy recommendation and three have issued a strong buy recommendation […]
